Flavanhan et al. initially found IDH mutant gliomas exhibited a disrupted CTCF boundary that allowed an aberrant interaction between a typical enhancer and the glioma oncogene PDGFRA, each originally insulated from each other, as an alternative method of oncogene activation (Fig. 5) [87]. The gene discussed is PDGFRA; the disease is glioma.